Feasibility and Effects of Inspiratory Muscle Training Combined With Blood Flow Restriction for Frail Older Adults
1. května 2026 aktualizováno: Pei-Shan, Tsai, Taipei Medical University
Feasibility and Effects of Inspiratory Muscle Training Combined With Blood Flow Restriction for Frail Older Adults: A Pilot Randomized Controlled Trial
This randomized controlled trial study aims to evaluate the feasibility and preliminary efficacy of a combined inspiratory muscle training (IMT) and blood flow restriction (BFR) intervention in frail older adults.
Outcomes of interest include feasibility, physical function, respiratory muscle strength, handgrip strength, five-times sit-to-stand performance, body composition, frailty level, fall efficacy, blood pressure, and adverse events.
Přehled studie
Postavení
Zatím nenabíráme
Podmínky
Intervence / Léčba
Detailní popis
This is a parallel randomized controlled trial. 30 participants who are older adults with frailty will be enrolled.
Eligible participants who complete the baseline measurements will be randomly allocated to a combined BFR and IMT intervention group (N=15) or in the control group with BFR and sham IMT (N=15).
Primary outcomes include feasibility and physical function (i.e., the Short Physical Performance Battery (SPPB), 6-minute walk test (6MWT), and Time Up and Go (TUG) test). Secondary outcomes include respiratory muscle strength, handgrip strength, five-times sit-to-stand performance, body composition, frailty level, fall efficacy, blood pressure, and adverse events. All outcomes will be assessed at baseline (T0) and immediately after the 6-week intervention period (T1) in both groups.
Typ studie
Intervenční
Zápis (Odhadovaný)
30
Fáze
- Nelze použít
Kontakty a umístění
Tato část poskytuje kontaktní údaje pro ty, kteří studii provádějí, a informace o tom, kde se tato studie provádí.
Studijní kontakt
- Jméno: Pei-Shan Tsai Professor, PhD
- Telefonní číslo: 6321 +886227361661
- E-mail: ptsai@tmu.edu.tw
Studijní místa
-
-
-
Taipei, Tchaj-wan, 11031
- Taipei Medical University
-
Kontakt:
- Pei-Shan Tsai Professor, PhD
- Telefonní číslo: 6321 +886227361661
- E-mail: ptsai@tmu.edu.tw
-
-
Kritéria účasti
Výzkumníci hledají lidi, kteří odpovídají určitému popisu, kterému se říká kritéria způsobilosti. Některé příklady těchto kritérií jsou celkový zdravotní stav osoby nebo předchozí léčba.
Kritéria způsobilosti
Věk způsobilý ke studiu
- Starší dospělý
Přijímá zdravé dobrovolníky
Ne
Popis
Inclusion Criteria:
- Community-dwelling adults aged 65 years and older who are classified as at least "vulnerable" using the Clinical Frailty Scale (score ≥4).
- Participants must have no cognitive impairment and be able to follow commands, as assessed by the Mini-Mental State Examination (MMSE).
Exclusion Criteria:
- (1) are unable to participate in exercise (e.g., due to severe musculoskeletal disorders)
- (2) have high-risk factors for exercise, such as uncontrolled hypertension (>150 mmHg systolic blood pressure (SBP) / >90 mmHg diastolic blood pressure (DBP), coagulation disorders, and deep venous thrombosis
- (3) have hematological disorders or are using hematology related-medications
- (4) have significant comorbidities, including a history of stroke, diabetes with severe complications, or cardiovascular diseases
- (5) chronic lung conditions (e.g., obstructive pulmonary disease, asthma), and
- (6) have participated in a structured exercise training program within the past 3 months at a frequency exceeding three sessions per week.
Studijní plán
Tato část poskytuje podrobnosti o studijním plánu, včetně toho, jak je studie navržena a co studie měří.
Jak je studie koncipována?
Detaily designu
- Primární účel: Léčba
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Dvojnásobek
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Experimentální: Intervention group
Participants in the experimental group will receive a 6 week combined BFR and IMT intervention
|
Each session will last approximately 60 minutes and will include three components: (1) an initial 3-minute IMT exercise performed at an intensity corresponding to rating of perceived exertion (RPE) 11-13 on the Borg 6-20 scale, (2) a 50-minute low-intensity exercise program combined with BFR, and (3) a second 3-minute IMT session at the same target intensity. For the IMT, the protocol follows a progressive intensity model, starting with 30% of the maximum inspiratory pressure (MIP) in Week 1 to allow participants to become familiar with the technique. The intensity will gradually increase to a target of 60% MIP by Week 6, based on the participants' tolerance. For the BFR, during weeks 1-2, participants will train at constant loads. From weeks 2-6, training loads will be increased. Cuff pressure will be prescribed relative to the calculated arterial occlusion pressure (AOP): 50% in weeks 1-2, 60% in weeks 3-4, and 70% in weeks 5-6 for both lower- and upper-body exercises. |
|
Falešný srovnávač: Control group
Participants in the control group will receive a 6-week combined combined BFR and sham IMT intervention.
|
Participants in the control group will perform the identical BFR exercise protocol as the intervention group.
However, IMT will be delivered at 2% of MIP, which is considered a sham condition and has not been shown to improve respiratory muscle function
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Recruitment rate
Časové okno: T0 = baseline; T1 = immediately after intervention
|
The recruitment rate will be calculated by dividing the number of recruited participants by the number of eligible participants
|
T0 = baseline; T1 = immediately after intervention
|
|
Attrition rate
Časové okno: T0 = baseline; T1 = immediately after intervention
|
Attrition rate is the proportion of randomized participants who withdraw from the study or are lost to follow-up before completing the final assessment.
|
T0 = baseline; T1 = immediately after intervention
|
|
Exercise Enjoyment
Časové okno: T0 = baseline; T1 = immediately after intervention
|
Enjoyment will be assessed using a single-item Exercise Enjoyment Scale, which asks participants, "How much did you enjoy the exercise session?).
Responses are rated on a 7 Likert scale ranging from 1 (not at all) to 7 (extremely)
|
T0 = baseline; T1 = immediately after intervention
|
|
Short Physical Performance Battery (SPPB)
Časové okno: T0 = baseline; T1 = immediately after intervention
|
The SPPB consists of three components-standing balance, gait speed, and repeated chair stands-each scored from 0 to 4 and summed to a total score ranging from 0 (worst performance) to 12 (best performance).
Lower SPPB scores indicate poorer physical function and a higher risk of adverse outcomes, with scores below 10 predictive of all-cause mortality in older adults.
|
T0 = baseline; T1 = immediately after intervention
|
|
6-Minute Walk Test (6MWT)
Časové okno: T0 = baseline; T1 = immediately after intervention
|
The 6MWT will be used to assess functional exercise capacity.
Participants will be instructed to walk as far as possible along a flat, straight course for 6 minutes, and the total distance is recorded.
|
T0 = baseline; T1 = immediately after intervention
|
|
Time Up to Go (TUG)
Časové okno: T0 = baseline; T1 = immediately after intervention
|
The TUG test is used to assess functional mobility, balance, and fall risk in older adults, incorporating a series of dynamic activities.
Participants will be instructed to rise from a chair, walk three meters at a comfortable pace, turn around, walk back to the chair, and sit down.
The total time taken to complete the task is recorded, with longer times indicating poorer functional mobility and higher fall risk
|
T0 = baseline; T1 = immediately after intervention
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Respiratory Muscle Strength
Časové okno: T0 = baseline; T1 = immediately after intervention
|
We will use the S-Index Test to evaluate the respiratory muscle function based on maximum dynamic inspiratory pressure, which is a recommended tool developed by POWERbreathe.
Participants will be advised to avoid strenuous exercise for 24h and to rest in a sitting position for 15 minutes before the assessment.
Then, they performed eight inspiratory maneuvers in a standing position, divided into three to four series of two to three repetitions.
|
T0 = baseline; T1 = immediately after intervention
|
|
Handgrip Strength
Časové okno: T0 = baseline; T1 = immediately after intervention
|
Handgrip strength will be evaluated to estimate the maximum upper-limb muscle function in older adults.
Participants will be seated with the shoulder adducted, the elbow flexed to 90°, and the forearm and wrist in a neutral position.
They will then be instructed to squeeze the dynamometer as forcefully as possible.
|
T0 = baseline; T1 = immediately after intervention
|
|
Five-times sit-to-stand
Časové okno: T0 = baseline; T1 = immediately after intervention
|
The five-times sit-to-stand test is simple to administer and has been widely applied in both clinical and research settings.
Participants will sit with their backs against the chair and be instructed to stand and sit five times as quickly as possible.
|
T0 = baseline; T1 = immediately after intervention
|
|
Frailty level
Časové okno: T0 = baseline; T1 = immediately after intervention
|
The Clinical Frailty Scale (CFS) is a 9-point global clinical measure ranging from 1 (very fit) to 9 (terminally ill), used to classify frailty severity in older adults.
A traditional Chinese version of the CFS has been validated in Taiwanese older adults, demonstrating acceptable inter-rater reliability and good criterion validity against established frailty measures
|
T0 = baseline; T1 = immediately after intervention
|
|
Fall Efficacy
Časové okno: T0 = baseline; T1 = immediately after intervention
|
The short form of the Falls Efficacy Scale-International (FES-I) includes 7 items rated on a 4-point Likert scale from 1 (not at all concerned) to 4 (very concerned).
The total score ranges from 7 to 28, with higher values indicating greater concern about falling
|
T0 = baseline; T1 = immediately after intervention
|
|
Adverse events
Časové okno: T0 = baseline; T1 = immediately after intervention
|
The study team will record adverse events during the intervention caused by the exercise, including falls, fractures, exercise-related pain, dizziness, muscle strain, sprains, respiratory and cardiac adverse events, and hospitalization.
|
T0 = baseline; T1 = immediately after intervention
|
|
Fat mass
Časové okno: T0 = baseline; T1 = immediately after intervention
|
Fat mass will be assessed using a body composition analyzer and recorded in kilograms
|
T0 = baseline; T1 = immediately after intervention
|
|
Fat-free mass
Časové okno: T0 = baseline; T1 = immediately after intervention
|
Fat-free mass will be assessed using a body composition analyzer and recorded in kilograms.
|
T0 = baseline; T1 = immediately after intervention
|
Další výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
The Borg Rating of Perceived Exertion (RPE) Scale
Časové okno: T0 = baseline; T1 = immediately after intervention
|
The Borg RPE scale reflects an individual's subjective perception of exercise intensity, integrating sensations of physical effort, breathlessness, and fatigue.
The scale ranges from 6 to 20, where 6 indicates "no exertion at all" and 20 indicates "maximal exertion."
This RPE score will be assessed every training session
|
T0 = baseline; T1 = immediately after intervention
|
|
Automated Office Blood Pressure
Časové okno: T0 = baseline; T1 = immediately after intervention
|
Automated Office Blood Pressure will be monitored before and after intervention to minimize cardiovascular risks and ensure that timely medical assistance is available for participants who experience any discomfort.
Upon arrival at the lab, participants will be asked to sit for at least 5 minutes before the first blood pressure reading; the average of two readings will be used for that visit
|
T0 = baseline; T1 = immediately after intervention
|
Spolupracovníci a vyšetřovatelé
Zde najdete lidi a organizace zapojené do této studie.
Sponzor
Termíny studijních záznamů
Tato data sledují průběh záznamů studie a předkládání souhrnných výsledků na ClinicalTrials.gov. Záznamy ze studií a hlášené výsledky jsou před zveřejněním na veřejné webové stránce přezkoumány Národní lékařskou knihovnou (NLM), aby se ujistily, že splňují specifické standardy kontroly kvality.
Hlavní termíny studia
Začátek studia (Odhadovaný)
1. května 2026
Primární dokončení (Odhadovaný)
1. října 2026
Dokončení studie (Odhadovaný)
1. října 2026
Termíny zápisu do studia
První předloženo
23. dubna 2026
První předloženo, které splnilo kritéria kontroly kvality
1. května 2026
První zveřejněno (Aktuální)
7. května 2026
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
7. května 2026
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
1. května 2026
Naposledy ověřeno
1. května 2026
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
Další identifikační čísla studie
- 2025-UAAT-UTS02
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
NE
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Ne
Studuje produkt zařízení regulovaný americkým úřadem FDA
Ne
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .